ESTRO Brachytherapy for Prostate Cancer 2018

Predicting disease progression free and cancer survival → Salvage radical prostatectomy offers 5-year biochemical relaps -free rates between

• postoperativ parameter ➢ SV –Invasion ➢ Lymph node metastases →

→ 55 and 69%

If pos. 5-fold risk of dying of PCa → good option in the patient with a life expectancy of at least 10 years, preradiation and preoperative prostate specific antigen less than 10 ng/ml ,

Touma NJ J Urol. 2005

PFP: 5-year 10-year 86.0% 86.0%

▪ preoperativ parameter ▪ PSA level < 10ng/ml

´ Bianco FJ IJROBP 2005